Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$554M |
| 2 |
Apple
AAPL
|
+$513M |
| 3 |
Illumina
ILMN
|
+$360M |
| 4 |
argenx
ARGX
|
+$304M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$482M |
| 2 |
Sherwin-Williams
SHW
|
+$314M |
| 3 |
AbbVie
ABBV
|
+$310M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$244M |
| 5 |
Atlassian
TEAM
|
+$233M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.85% |
| 2 | Healthcare | 19.69% |
| 3 | Industrials | 10.47% |
| 4 | Financials | 10.02% |
| 5 | Consumer Discretionary | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Icon
ICLR
$12.7B
| $179M | 0.12% |
838,246
-148,318
| -15% | -$33M |
|
177
Schwab US Large- Cap ETF
SCHX
$74.6B
| $178M | 0.12% |
11,009,955
-613,938
| -5% | -$9.66M |
|
178
RB Global
RBA
$17.3B
| $176M | 0.12% |
3,128,099
-669,039
| -18% | -$39.4M |
|
179
Casey's General Stores
CASY
$30.9B
| $172M | 0.11% |
794,960
-11,913
| -1% | -$2.6M |
|
180
Oracle
ORCL
$431B
| $171M | 0.11% |
1,837,507
-469,351
| -20% | -$41.2M |
|
181
Keysight
KEYS
$58B
| $167M | 0.11% |
1,033,369
+974,157
| +1,645% | +$165M |
|
182
Visteon
VC
$2.78B
| $164M | 0.11% |
1,047,863
-437,341
| -29% | -$67.7M |
|
183
Constellium
CSTM
$3.96B
| $163M | 0.11% |
10,649,744
+242,568
| +2% | +$3.53M |
|
184
Regeneron Pharmaceuticals
REGN
$81.9B
| $162M | 0.11% |
197,071
-49,951
| -20% | -$37.7M |
|
185
Alight
ALIT
$398M
| $161M | 0.11% |
872,930
+237,606
| +37% | +$43.6M |
|
|
AXON
186
Axon Enterprise
AXON
$47.8B
| $159M | 0.1% |
707,671
-272,211
| -28% | -$54.1M |
|
187
Stellantis
STLA
$21.2B
| $159M | 0.1% |
8,762,554
+2,634,997
| +43% | +$44M |
|
188
Burlington
BURL
$23.4B
| $156M | 0.1% |
770,832
-501,616
| -39% | -$110M |
|
189
Apollo Global Management
APO
$74B
| $155M | 0.1% |
2,461,039
-1,090,672
| -31% | -$73M |
|
190
Walker & Dunlop
WD
$1.44B
| $155M | 0.1% |
2,034,574
+31,253
| +2% | +$2.71M |
|
191
PTC Therapeutics
PTCT
$6.18B
| $155M | 0.1% |
3,196,304
+1,169,162
| +58% | +$53.4M |
|
192
Euronet Worldwide
EEFT
$2.64B
| $154M | 0.1% |
1,376,643
-85,335
| -6% | -$9.23M |
|
193
Travere Therapeutics
TVTX
$5.84B
| $154M | 0.1% |
6,845,813
+1,754,528
| +34% | +$37.3M |
|
194
Chipotle Mexican Grill
CMG
$41.5B
| $152M | 0.1% |
4,462,150
+157,850
| +4% | +$4.96M |
|
|
FOLD
195
DELISTED
Amicus Therapeutics
FOLD
| $151M | 0.1% |
13,610,435
-84,114
| -0.6% | -$1.04M |
|
196
Organon & Co
OGN
$3.57B
| $149M | 0.1% |
6,324,728
-5,695,846
| -47% | -$153M |
|
197
Yum China
YUMC
$16.4B
| $149M | 0.1% |
2,370,452
-187,901
| -7% | -$11.3M |
|
198
Xylem
XYL
$28.6B
| $147M | 0.1% |
1,402,244
+629,275
| +81% | +$65.7M |
|
199
Magnolia Oil & Gas
MGY
$6.15B
| $146M | 0.1% |
6,693,932
-583,409
| -8% | -$12.9M |
|
200
Pfizer
PFE
$154B
| $146M | 0.1% |
3,579,172
+54,860
| +2% | +$2.37M |
|
Similar funds
Janus Henderson Group's Q1 2023 Portfolio in Review
As of Q1 2023, Janus Henderson Group held 2,845 positions worth $152B, up 8.3% from $140B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Janus Henderson Group's Q1 2023 filing shows 389 new, 1,670 increased, 578 reduced and 160 closed positions. Its largest new stake was GE HealthCare: 882,749 shares worth $72.4M. The largest sale was Meta Platforms (Facebook), an estimated $482M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 28% a quarter earlier, followed by Healthcare and Industrials.
- Janus Henderson Group's largest Q1 2023 buy was GE HealthCare: 882,749 shares worth $72.4M.
- Janus Henderson Group added most to Linde in Q1 2023, an estimated $554M increase.
- Janus Henderson Group's biggest Q1 2023 reduction was Meta Platforms (Facebook), cutting an estimated $482M.
- Janus Henderson Group fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $31.7M.
- Janus Henderson Group's ten largest holdings make up 24% of its $152B portfolio in Q1 2023.
- Janus Henderson Group opened 389 new positions and closed 160 in Q1 2023.
- Janus Henderson Group's portfolio value rose 8.3% quarter-over-quarter to $152B.
Based on Janus Henderson Group's 13F filing for Q1 2023, filed 15 May 2023.